Comprehensive bibliography on the use of thromboelastography in COVID-19:
ARTICLE TITLE |
JOURNAL |
AUTHORS |
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated with adult respiratory distress syndrome (ARDS)? |
Moore HB, Barrett CD, Moore EE, McIntyre RC, Moore PK, Talmor DS, Moore FA, Yaffe MB |
|
Hypercoagulability of COVID-19 Patients in Intensive Care Unit. A Report of Thromboelastography Findings and Other Parameters of Hemostasis |
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A |
|
Coagulopathy in COVID-19: Review and Recommendations |
https://www.facs.org/-/media/files/covid19/umiami_study_uses_of_coagulopathy.ashx |
Brandon M. Parker |
Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA):A case series |
Barrett CD, Oren-Grinberg A, Chao E, Moraco, AH, Martin, MJ, Reddy SH, Ilg AM, Jhunjhunwala R, Uribe M, Moore HB, Moore EE, Baedorf-Kassis EN, Krajewski ML, Talmor DS, Shaefi S, Yaffe MB |
|
Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection |
Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC |
|
Technologies to Optimize the Care of Severe COVID-19 Patients for Healthcare Providers Challenged by Limited Resources |
Rubulotta F, Soliman-Aboumarie H, Filbey K, Geldner G, Kuck K, Ganau M, Hemmerling TM |
|
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 |
Maatman TK, Jalali F, Feizpour C, Douglas 2nd A, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreuttz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD |
|
Global haemostatic tests in rapid diagnosis and management of COVID‑19 associated coagulopathy in acute limb ischaemia |
Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Ang MK, Lau SL, Ong KH, Ng J |
|
Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019 who are critically ill |
JAMA Network Open. 2020;3(6):e2011192. doi:10.1001/jamanetworkopen.2020.11192 |
Mortus JR, Manek SE, Brubaker LS, Loor M, Cruz MA, Trautner BW, Rosengart TK |
COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps? |
Anesthesia & Analgesia: November 2020 - Volume 131 - Issue 5 - p 1324-1333 doi:10.1213/ANE.000000000000514 |
Gorlinger K, Dirkmann D, Gandhi A, Simioni P |
A proposal for staging COVID-19 coagulopathy |
Thachil J, Cushman M, & Srivastava A |
|
Thromboelastography profiles of critically ill patients with coronavirus disease 2019 |
Yuriditsky E, Horowitz JM, Brosnahan S, McVoy L, Berger JS |
|
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019 |
Hightower S, Elllis H, Collen J, Ellis J, Grasso I, Roswarski J, Cap AR, Chung K, Prescher L, Kavanaugh M, Brown T, Nau M, Clark P |
|
Pulmonary angiopathy in severe COVID-19: Physiologic, imaging and hematologic observations |
Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR |
|
Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry |
Thromb Haemost 2020; 120(11): 1594-1596 DOI:10.1055/s-0040-171421 |
Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA |
Anti Xa activity after high dose LMWH thrombosis prophylaxis in COVID 19 patients at the intensive care unit |
Thromb Res. 2020 Jul 22;196:1-3. doi:10.1016/j.thromres.2020.07.035. |
Vlot EA, Van den Dool EJ, Hackeng CM, Sohne M, Noordzij EJ, Van Dongen EPA, |
Disease Severity Assessed By Thromboelastography In A Minority Population With Covid-19 |
https://www.ahajournals.org/doi/10.1161/circ.142.suppl_3.16780 |
Bliden K, Rout A, Chaudhary R, Barnes J, Tantry U, Gurbel PA |
Heightened Platelet Function: An Unrecognized Component Of The Covid Hypercoagulability State |
https://www.ahajournals.org/doi/10.1161/circ.142.suppl_3.16676 |
Bliden K, Rout A, Chaudhary R, Barnes J, Tantry U, Gurbel PA |
Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients |
J Crit Care. 2020 Sep 3;60:249-252. doi:10.1016/j.jcrc.2020.08.026. |
Stattin K, Lipcsey M, Andersson H, Pontein E, Anderberg S, Gradin A, Larsson A, Lubenow N, von Seth M, Rubertsson S, Hultstrom M, Frithiof R |
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study |
Crit Care. 2020 Sep 18;24(1):561. doi:10.1186/s13054-020-03260-3 |
Shah A, Donovan K, McHugh A, Pandey M, Aaron L, Bradbury CA, Stanworth SJ, Alikhan R, Von Kier S, Maher K, Curry N, Shapiro S, Rowland MJ, Thomas M, Mason R, Holland M, Holmes T, Ware M,, Gurney S, and McKechnie SR |
Usefulness of combining D-dimers with thromboelastography |
J Am Coll Surg. 2020 Sep 17;S1072-7515(20)30550-0. doi:10.1016/j.jamcollsurg.2020.07.004. |
Thachil J |
Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients |
Sadd C, Rowe T, Nazeef M, Kory P, Sultan S, Faust H |
|
Thromboelastography findings in critically ill COVID-19 patients |
Salem N, Atallah B, El Nekidy WS, Sadik ZG, Park WM, Mallat J |
|
COVID-19 infection-related coagulopathy and viscoelastic methods: A paradigm for their clinical utility in critical illness |
Tsantes AE, Tsantes AG, Kokoris SI, Bonovas S, Frantzeskaki F, Tsanfaris I, Kopterides T |
|
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: Implications for clinical practice and future investigations |
Crit Care 24, 559 (2020). doi.org/10.1186/s13054-020-03273-y |
Flaczyk A., Rosovsky R.P., Reed C.T., Bankhead-Kendall B.K., Bittner E.A., Chang M.G |
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review |
Res Pract Thromb Haemost. 2020;4:524–531 DOI:10.1002/rth2.12357 |
Barrett C.D., Moore H.B., Moore E.E., McIntyre R.C., Moore P.K., Burke J., Hua F., Apgar J., Talmor D.S., Sauaia A., Liptzin D.R., Veress L.A., Yaffe M.B. |
Understanding the COVID -19 coagulopathy spectrum |
Anaesthesia. 2020 May 21 : 10.1111/anae.15141. doi:10.1111/anae.15141 |
Thacil J and Agarwal S |
Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection |
Acta Med Port 2021 Jan;34(1):44-55. doi.org/10.20344/amp.14784 |
Rodrigues A, Sevivas TS, Pereira CL, Caiado A, Nunes AR |
Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19 |
Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Sttenkamp J, Kell DB, Pretorius E |
|
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19 |
Song J.-C., Wang G., Zhang W., Zhang Y., Li W.-Q., Zhou Z. |
|
Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations |
EClinicalMedicine The Lancet. Volumes 29-30, December 2020: 100647 |
Chaudhary R, Bliden KP, Kreutz RP, Jeong YH, Tantry US, Levy JH, Gurbel PA |
Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy |
Hranjec T, Estreicher M, Rogers B, Kohler L, Solomon R, Hennessy S, Cibulas M, Hurst D, Hegazy M, Lee J, Perez D, Doctor N, Kiffin C, Pigneri D, LaGuardia H, Shaw K, Arenas J, Rosenthal A, Katz RS, Sawyer RG, Pepe PE. |
|
Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia |
Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN |
|
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study |
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12466-12479. doi:10.26355/eurrev_202012_24043 |
Bocci MG, Maviglia R, Consalvo LM, Grieco DL, Montini L, Mercurio G, Nardi G, Pisapia L, Cutuli SL, Biasucci DG, Gori C, Rosenkranz R, De Candia E, Carelli S, Natalini D, Antonelli M, Franceschi F |
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation |
Nat Rev Cardiol. 2020 Nov 19;1-16. doi:10.1038/s41569-020-00469-1. |
Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. |
Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series |
Castro-Verdes M, Gkouma A, Wort J, Ridge C, Mirsadraee S, Padley S, Sheikh A, Singh S |
Source: PUBMED search using the following terms: "Covid-19" OR "Coronavirus" OR "sarscov2") AND ("viscoelastic" OR "VHA" OR "TEG" OR "thromboelastography" OR "thromboelastographic" OR "thromboelastograph" OR "thrombelastograph")
© 2021 Haemonetics Corporation. Haemonetics, and TEG,are trademarks or registered trademarks of Haemonetics Corporation in the USA, other countries or both. 02.2021 USA. COL-COPY-001499-US(AA)